Silencing of Apoptosis-Inducing factor and poly(ADP-ribose) glycohydrolase reveals novel roles in breast cancer cell death after chemotherapy

Molecular Cancer

Volumn 11, Issue , 2012, Pages

  Feng, Xiaoxing ^a   Zhou, Yiran ^a   Proctor, Alicia M ^a   Hopkins, Mandi M ^a   Liu, Mengwei ^a   Koh, David W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Apoptosis inducing factor; Breast cancer; Caspase independent cell death; PARG; Poly(ADP ribose); RNA interference

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; GLYCOSIDASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CATALYSIS; CELL DEATH; CELL STRAIN MCF 7; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; RNA INTERFERENCE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTINEOPLASTIC AGENTS; APOPTOSIS INDUCING FACTOR; BREAST NEOPLASMS; CASPASE 8; CELL DEATH; CELL LINE, TUMOR; CELL NUCLEUS; DNA DAMAGE; FEMALE; GENE SILENCING; GLYCOSIDE HYDROLASES; HUMANS; RNA INTERFERENCE;

EID: 84864258177     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-11-48     Document Type: Article

References (51)

1. Juarez-Salinas H, Sims JL, Jacobson MK. Poly(ADP-ribose) levels in carcinogen-treated cells. Nature 1979, 282:740-741. 10.1038/282740a0, 229416.
2. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G, Penninger JM, Peleato ML, Kroemer G, Susin SA. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 2001, 276:16391-16398. 10.1074/jbc.M010498200, 11278689.
3. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD, Ebersberger I, Nakashima T, Sarao R, Neely G, et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007, 131:476-491. 10.1016/j.cell.2007.08.047, 17981116.
4. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001, 410:549-554. 10.1038/35069004, 11279485.
5. Artus C, Boujrad H, Bouharrour A, Brunelle MN, Hoos S, Yuste VJ, Lenormand P, Rousselle JC, Namane A, England P, et al. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J 2010, 29:1585-1599. 10.1038/emboj.2010.43, 2876946, 20360685.
6. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, Yuan J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323. 10.1016/j.cell.2008.10.044, 2621059, 19109899.
7. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446. 10.1038/17135, 9989411.
8. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB j : official publication of the Federation of American Societies for Exp Biol 2000, 14:729-739.
9. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F, Youle RJ. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003, 22:4385-4399. 10.1093/emboj/cdg423, 202365, 12941691.
10. Arnoult D, Parone P, Martinou JC, Antonsson B, Estaquier J, Ameisen JC. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 2002, 159:923-929. 10.1083/jcb.200207071, 2173976, 12486111.
11. Cande C, Vahsen N, Garrido C, Kroemer G. Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ 2004, 11:591-595.
12. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297:259-263. 10.1126/science.1072221, 12114629.
13. Xiao CY, Chen M, Zsengeller Z, Szabo C. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor. J Pharmacol Exp Ther 2004, 310:498-504. 10.1124/jpet.104.066803, 15054118.
14. Brochu G, Duchaine C, Thibeault L, Lagueux J, Shah GM, Poirier GG. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim Biophys Acta 1994, 1219:342-350. 10.1016/0167-4781(94)90058-2, 7918631.
15. Zhou Y, Feng X, Koh DW. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase. Biochemistry 2011, 50:2850-2859. 10.1021/bi101829r, 21366272.
16. Wang Y, Kim NS, Haince JF, Kang HC, David KK, Andrabi SA, Poirier GG, Dawson VL, Dawson TM. Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1-Dependent Cell Death (Parthanatos). Sci Signal 2011, 4:ra20. 10.1126/scisignal.2000902, 3086524, 21467298.
17. David KK, Andrabi SA, Dawson TM, Dawson VL. Parthanatos, a messenger of death. Front biosci : a j and virtual library 2009, 14:1116-1128.
18. Wang H, Yu SW, Koh DW, Lew J, Coombs C, Bowers W, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 2004, 24:10963-10973. 10.1523/JNEUROSCI.3461-04.2004, 15574746.
19. Kauppinen TM, Suh SW, Berman AE, Hamby AM, Swanson RA. Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J of cereb blood flow and metab : official j of the Int Soc Cereb Blood Flow and Metab 2009, 29:820-829.
20. Mabley JG, Jagtap P, Perretti M, Getting SJ, Salzman AL, Virag L, Szabo E, Soriano FG, Liaudet L, Abdelkarim GE, et al. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm research : official journal of the European Histamine Res Soc [et al.] 2001, 50:561-569.
21. Barton C, Davies D, Balkwill F, Burke F. Involvement of both intrinsic and extrinsic pathways in IFN-gamma-induced apoptosis that are enhanced with cisplatin. European j cancer 2005, 41:1474-1486.
22. Zhuang Y, Miskimins WK. Metformin induces both caspase-dependent and poly(ADP-ribose) polymerase-dependent cell death in breast cancer cells. Molecular cancer research : MCR 2011, 9:603-615. 10.1158/1541-7786.MCR-10-0343, 3096726, 21422199.
23. Gallego MA, Joseph B, Hemstrom TH, Tamiji S, Mortier L, Kroemer G, Formstecher P, Zhivotovsky B, Marchetti P. Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas. Oncogene 2004, 23:6282-6291. 10.1038/sj.onc.1207835, 15286713.
24. Skyrlas A, Hantschke M, Passa V, Gaitanis G, Malamou-Mitsi V, Bassukas ID. Expression of apoptosis-inducing factor (AIF) in keratoacanthomas and squamous cell carcinomas of the skin. Exp derm 2011, 20:674-676. 10.1111/j.1600-0625.2011.01249.x, 21410769.
25. Ahn HJ, Kim YS, Kim JU, Han SM, Shin JW, Yang HO. Mechanism of taxol-induced apoptosis in human SKOV3 ovarian carcinoma cells. J Cell Biochem 2004, 91:1043-1052. 10.1002/jcb.20006, 15034938.
26. Liu T, Biddle D, Hanks AN, Brouha B, Yan H, Lee RM, Leachman SA, Grossman D. Activation of dual apoptotic pathways in human melanocytes and protection by survivin. The J invest derm 2006, 126:2247-2256.
27. Jacobson EL, Antol KM, Juarez-Salinas H, Jacobson MK. Poly(ADP-ribose) metabolism in ultraviolet irradiated human fibroblasts. J Biol Chem 1983, 258:103-107.
28. Ackland SP, Anton A, Breitbach GP, Colajori E, Tursi JM, Delfino C, Efremidis A, Ezzat A, Fittipaldo A, Kolaric K, et al. Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study. J clin oncol : official j Am Soc of Clin Oncol 2001, 19:943-953.
29. Dunphy FR, Spitzer G, Buzdar AU, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, et al. Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J clin oncol : official j Am Soc Clin Oncol 1990, 8:1207-1216.
30. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 2003, 8:345-352. 10.1023/A:1024116916932, 12815277.
31. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998, 9:267-276. 10.1016/S1074-7613(00)80609-3, 9729047.
32. Ivanov VN, Kehrl JH, Ronai Z. Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis. Oncogene 2000, 19:933-942. 10.1038/sj.onc.1203415, 10702802.
33. Jacobson EL, Smith JY, Wielckens K, Hilz H, Jacobson MK. Cellular recovery of dividing and confluent C3H10T1/2 cells from N-methyl-N'-nitro-N-nitrosoguanidine in the presence of ADP-ribosylation inhibitors. Carcinogenesis 1985, 6:715-718. 10.1093/carcin/6.5.715, 2988808.
34. Blenn C, Althaus FR, Malanga M. Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death. Biochem J 2006, 396:419-429. 10.1042/BJ20051696, 1482814, 16526943.
35. Erdelyi K, Bai P, Kovacs I, Szabo E, Mocsar G, Kakuk A, Szabo C, Gergely P, Virag L. Dual role of poly(ADP-ribose) glycohydrolase in the regulation of cell death in oxidatively stressed A549 cells. FASEB j : official publication of the Federation of Am Soc Exp Biol 2009, 23:3553-3563.
36. Ame JC, Fouquerel E, Gauthier LR, Biard D, Boussin FD, Dantzer F, de Murcia G, Schreiber V. Radiation-induced mitotic catastrophe in PARG-deficient cells. J Cell Sci 2009, 122:1990-2002. 10.1242/jcs.039115, 19454480.
37. Koh DW, Lawler AM, Poitras MF, Sasaki M, Wattler S, Nehls MC, Stoger T, Poirier GG, Dawson VL, Dawson TM. Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality. Proc Natl Acad Sci USA 2004, 101:17699-17704. 10.1073/pnas.0406182101, 539714, 15591342.
38. Hanai S, Kanai M, Ohashi S, Okamoto K, Yamada M, Takahashi H, Miwa M. Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc Natl Acad Sci USA 2004, 101:82-86. 10.1073/pnas.2237114100, 314142, 14676324.
39. Meyer-Ficca ML, Meyer RG, Coyle DL, Jacobson EL, Jacobson MK. Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp Cell Res 2004, 297:521-532. 10.1016/j.yexcr.2004.03.050, 15212953.
40. Min W, Cortes U, Herceg Z, Tong WM, Wang ZQ. Deletion of the nuclear isoform of poly(ADP-ribose) glycohydrolase (PARG) reveals its function in DNA repair, genomic stability and tumorigenesis. Carcinogenesis 2010, 31:2058-2065. 10.1093/carcin/bgq205, 20926829.
41. Leung AK, Vyas S, Rood JE, Bhutkar A, Sharp PA, Chang P. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 2011, 42:489-499. 10.1016/j.molcel.2011.04.015, 21596313.
42. Pinsky SD, Tew KD, Smulson ME, Woolley PV. Modification of L1210 cell nuclear proteins by 1-methyl-1-nitrosourea and 1-methyl-3-nitro-1-nitrosoguanidine. Cancer Res 1979, 39:923-928.
43. Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004, 3:294-300. 10.1177/1534735404270335, 15523100.
44. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371:346-347. 10.1038/371346a0, 8090205.
45. Wang ZQ, Stingl L, Morrison C, Jantsch M, Los M, Schulze-Osthoff K, Wagner EF. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 1997, 11:2347-2358. 10.1101/gad.11.18.2347, 316515, 9308963.
46. Zhou Y, Feng X, Koh DW. Enhanced DNA accessibility and increased DNA damage induced by the absence of poly(ADP-ribose) hydrolysis. Biochemistry 2010, 49:7360-7366. 10.1021/bi100979j, 20687516.
47. Flamant L, Notte A, Ninane N, Raes M, Michiels C. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer 2010, 9:191. 10.1186/1476-4598-9-191, 3098009, 20626868.
48. Small GW, Somasundaram S, Moore DT, Shi YY, Orlowski RZ. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK. J Pharmacol Exp Ther 2003, 307:861-869. 10.1124/jpet.103.055806, 14557375.
49. Sun L, Cai L, Yu Y, Meng Q, Cheng X, Zhao Y, Sui G, Zhang F. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin. Acta Biochim Biophys Sin 2007, 39:999-1007. 10.1111/j.1745-7270.2007.00361.x, 18064393.
50. Xu H, Yan M, Patra J, Natrajan R, Yan Y, Swagemakers S, Tomaszewski JM, Verschoor S, Millar EK, van der Spek P, et al. Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers. Breast cancer research : BCR 2011, 13:R9. 10.1186/bcr2814, 3109576, 21255398.
51. Yeruva L, Hall C, Elegbede JA, Carper SW. Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin. Anti-cancer drugs 2010, 21:1-9. 10.1097/CAD.0b013e32832a68ad, 2907645, 19820395.